01 / 05
New Allergy Drug Protects Against Severe Food Reactions

Nature | Accidents, Injuries & Poisonings

New Allergy Drug Protects Against Severe Food Reactions

“For people with food allergies, accidentally eating the wrong thing could prove deadly. Now, for the first time, an asthma drug has been shown to protect people from severe reactions if they ingest a small amount of a food they’re allergic to.

In a study reported on 25 February in The New England Journal of Medicine, researchers tested a drug called omalizumab in 3 adults and 177 children aged between one and 17 who were severely allergic to peanuts and at least two other foods. After about four months of treatment, 67% of those who received the drug were able to ingest the equivalent of two or three peanuts without it causing a significant reaction, compared with just 7% of those who received a placebo. Omalizumab seemed to be similarly effective at raising participants’ tolerance to other foods they were allergic to, including cashews, milk and eggs.”

From Nature.

UW–Madison News | Health & Medical Care

Researchers Develop Better Way to Make Painkiller from Trees

“Scientists at the University of Wisconsin–Madison have developed a cost-effective and environmentally sustainable way to make a popular pain reliever and other valuable products from plants instead of petroleum.

Building on a previously patented method for producing paracetamol – the active ingredient in Tylenol – the discovery promises a greener path to one of the world’s most widely used medicines and other chemicals.”

From UW–Madison News.

Wall Street Journal | Noncommunicable Disease

The New, More-Hopeful Face of Alzheimer’s Disease

“For as long as I’ve been practicing medicine, Alzheimer’s disease has been, essentially, a death sentence. You give the diagnosis, and you prepare the patient and the family for the worst.

Until now…

Thanks to new developments in the early detection and management of Alzheimer’s, as well as new medications, many patients can slow the course of the disease and boost their well-being. The result is that more Alzheimer’s patients are able to live relatively normal lives for much longer than previously—several years, at least, and often longer.”

From Wall Street Journal.

NBC News | Vaccination

Chlamydia Vaccine Shows Promise in Early Trial

“An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet Infectious Diseases. 

There is currently no vaccine to protect against the sexually transmitted infection, which is the most common bacterial STI in the United States…

The phase 1 clinical trial, led by researchers in the United Kingdom and Denmark, found that the experimental vaccine was safe and induced an immune response.”

From NBC News.

The Daily Upside | Vaccination

Moderna Inches Nearer to Successful Cancer Vaccine

“Moderna has long touted that the mRNA vaccine technology it helped revolutionize during the global dash to create a coronavirus vaccine could be repurposed for a variety of medical uses. This vaccine, mRNA-4157, uses the method to train the immune system to identify and attack specific mutations in cancer cells.

The early-stage trial, conducted on patients already prescribed Merck’s Keytruda to treat certain types of head and neck cancer, produced some positive results — and hinted at an even brighter future for the vaccine.”

From The Daily Upside.